Making a case for an endocannabinoid deficiency

Dr. Ethan Russo (no relation) is a consultant for GW Pharmaceuticals and a proponent of medical marijuana.

This article is the latest justification that “migraine, fibromyalgia, irritable bowel syndrome, and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.”

Actually, I changed my mind. I’m not going to summarize it. You can read his entire case for a endocannabinoid deficiency here. Published in 2004, Dr. Russo has been flogging this poor horse for a long time.

The bottom line?
Literature searchers I conducted show no evidence that cannabinoids are useful to treat migraine, fibromyalgia, or irritable bowel syndrome.

4/12/08 19:21 JR

This entry was posted on Saturday, April 12th, 2008 at 7:27 PM and is filed under Fibromyalgia, Irritable Bowel Syndrome, Marijuana (Cannabinoids), Migraine. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.